Search Results - "MILFORD, D"

Refine Results
  1. 1

    Assessing bone mineralisation in children with chronic kidney disease: what clinical and research tools are available? by Lalayiannis, A.D., Crabtree, N.J., Fewtrell, M., Biassoni, L., Milford, D.V., Ferro, C.J., Shroff, R.

    Published in Pediatric nephrology (Berlin, West) (01-06-2020)
    “…Mineral and bone disorder in chronic kidney disease (CKD-MBD) is a triad of biochemical imbalances of calcium, phosphate, parathyroid hormone and vitamin D,…”
    Get full text
    Journal Article
  2. 2
  3. 3

    G363 Case reports on serious respiratory complications after renal transplant in obese children: Can these be avoided? by Verma, P, Milford, D

    Published in Archives of disease in childhood (01-04-2014)
    “…Aims To present two obese children who suffered serious post operative respiratory complications after renal transplantation and to discuss strategies we have…”
    Get full text
    Journal Article
  4. 4

    A 10‐year longitudinal follow‐up study of a U.K. paediatric transplant population to assess for skin cancer by Foo, S.H., Nightingale, P.G., Gazzani, P., Bader, E., Ogboli, M., Martin‐Clavijo, A., Milford, D.V., Kelly, D.A., Moss, C., Thomson, M.A.

    Published in British journal of dermatology (1951) (01-12-2018)
    “…Summary Background Our earlier study, published in 2004,found no skin cancer in a cohort of paediatric organ transplant recipients (POTRs) 5–16 years…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Successful Isolated Liver Transplantation in a Child with Atypical Hemolytic Uremic Syndrome and a Mutation in Complement Factor H by Haller, W., Milford, D. V., Goodship, T. H. J., Sharif, K., Mirza, D. F., McKiernan, P. J.

    Published in American journal of transplantation (01-09-2010)
    “…A male infant was diagnosed with atypical hemolytic uremic syndrome (aHUS) at the age of 5.5 months. Sequencing of the gene (CFH) encoding complement factor H…”
    Get full text
    Journal Article
  8. 8

    G333(P) Serum biomarkers, but not dual-energy x-ray absorptiometry (DXA), predict bone mineral density in children with chronic kidney disease by Lalayiannis, AD, Crabtree, NJ, Askiti, V, Mitsioni, A, Fewtrell, M, Kaur, A, Milford, DV, Shroff, R

    Published in Archives of disease in childhood (01-10-2020)
    “…IntroductionCurrently available biomarkers and Dual-energy X-ray Absorptiometry (DXA) are thought to be poor predictors of bone mineral density (BMD). The 2017…”
    Get full text
    Journal Article
  9. 9
  10. 10

    G440 A Snapshot of acute kidney injury in tertiary paediatric centres in the united kingdom by Verghese, GK, Oni, L, Milford, DV, Holt, RCL

    Published in Archives of disease in childhood (01-05-2017)
    “…BackgroundThe burden of acute kidney injury (AKI) in the paediatric age group is unknown, partly due to the lack of a universally agreed definition in the…”
    Get full text
    Journal Article
  11. 11

    ARC syndrome: an expanding range of phenotypes by Eastham, K M, McKiernan, P J, Milford, D V, Ramani, P, Wyllie, J, van't Hoff, W, Lynch, S A, Morris, A A M

    Published in Archives of disease in childhood (01-11-2001)
    “…AIM To describe the clinical phenotype in infants with ARC syndrome, the association of arthrogryposis, renal tubular acidosis, and cholestasis. METHODS The…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Nodular glomerulosclerosis in a patient with cystic fibrosis, but not diabetes mellitus: A paediatric case by Lalayiannis, A.D, Thompson, C, Malcomson, R, Milford, D.V

    Published in Respiratory medicine case reports (01-01-2016)
    “…Abstract Background Nodular glomerulosclerosis is seen in insulin dependent diabetic patients with nephropathy. Kimmelstiel-Wilson nodules on biopsy are…”
    Get full text
    Journal Article
  14. 14
  15. 15

    O6.10 GLIOMA CELL VEGFR-2 EXPRESSION IMPAIRS CHEMOTHERAPEUTIC AND ANTIANGIOGENIC TREATMENTS IN PTEN-DEFICIENT GLIOBLASTOMA by Weiler, M., Kessler, T., Sahm, F., Blaes, J., Osswald, M., Milford, D., Urban, S., Ruiz de Almodovar, C., Heiland, S., Wick, W.

    Published in Neuro-oncology (Charlottesville, Va.) (01-09-2014)
    “…BACKGROUND: Given the recent failure of bevacizumab (BEV) in extending overall survival of patients with newly diagnosed glioblastoma, tissue biomarkers…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19

    Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11 beta-hydroxysteroid dehydrogenase type 2 gene by Stewart, P M, Krozowski, Z S, Gupta, A, Milford, D V, Howie, A J, Sheppard, M C, Whorwood, C B

    Published in The Lancet (British edition) (13-01-1996)
    “…11 beta-hydroxysteroid dehydrogenase (11 beta-HSD) catalyses the interconversion of hormonally active cortisol to inactive cortisone and is vital for dictating…”
    Get more information
    Journal Article
  20. 20

    Skin surveillance of a U.K. paediatric transplant population by Thomson, M.A., Suggett, N.R., Nightingale, P.G., Milford, D.V., Baumann, U., Kelly, D.A., Moss, C., Hill, V.A.

    Published in British journal of dermatology (1951) (01-01-2007)
    “…Summary Background  Solid organ transplant recipients are at increased risk of skin cancer. Melanoma is less common than nonmelanoma skin cancer (NMSC)…”
    Get full text
    Journal Article